Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
The Prostate|May 7, 2014
Identification of specific Y chromosomes associated with increased prostate cancer riskLisa A Cannon-Albright, James M Farnham, Matthew Bailey, et al.
International Journal of Environmental Research and Public Health|December 23, 2022
Comorbidity and Cancer Disease Rates among Those at High-Risk for Alzheimer's Disease: A Population Database AnalysisDavid Valentine, Craig C Teerlink, James M Farnham, et al.
Neuro-Oncology|July 10, 2020
Genome-wide analysis of high-risk primary brain cancer pedigrees identifies PDXDC1 as a candidate brain cancer predisposition geneLisa A Cannon-Albright, James M Farnham, Jeffrey Stevens, et al.
Obstetrics and Gynecology|November 23, 2011
Identification of six loci associated with pelvic organ prolapse using genome-wide association analysisKristina Allen-Brady, Lisa Cannon-Albright, James M Farnham, et al.
Neurology|May 13, 2016
Population-based risks for cancer in patients with ALSSummer B Gibson, Diana Abbott, James M Farnham, et al.
International Journal of Cancer|March 7, 2020
A population-based study of testicular cancer risk among children and young adults from Norway and Utah, USARuby Del Risco Kollerud, Hege S Haugnes, Bjørgulf Claussen, et al.
Neurology|March 15, 2019
Relative risk for Alzheimer disease based on complete family historyLisa A Cannon-Albright, Norman L Foster, Karen Schliep, et al.
Cancer Medicine|November 1, 2019
Increased risk for other cancers in individuals with Ewing sarcoma and their relativesDiana Abbott, Schuyler O'Brien, James M Farnham, et al.
European Journal of Human Genetics : EJHG|May 1, 2018
Genome-wide linkage analysis in Spanish melanoma-prone families identifies a new familial melanoma susceptibility locus at 11qMiriam Potrony, Joan Anton Puig-Butille, James M Farnham, et al.
Molecular Cancer Therapeutics|December 28, 2018
Germline Variant in <i>SLCO2B1</i> and Response to Abiraterone Acetate Plus Prednisone (AA) in New-onset Metastatic Castration-resistant Prostate Cancer (mCRPC)Andrew W Hahn, David M Gill, Austin Poole, et al.
Pageof 4